AstraZeneca PLC's asthma rescue medication Airsupra has received the green light from US regulators, boosting the UK major's respiratory franchise which is feeling the pinch due to declining revenues of the blockbuster Symbicort.
The US Food and Drug Administration has approved Airsupra, which has been developed with Avillion LLP, making it the...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
